Safety and Pharmacokinetics of Single Intravenous Doses of Peginesatide in Healthy Volunteers

NCT00097747 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Anemia
Chronic Kidney Disease
Chronic Renal Failure
Cancer

Interventions

DRUG: Placebo
DRUG: peginesatide

Sponsor

Affymax